SLCO1B1 Genetic Variant Associated With Statin‐Induced Myopathy: A Proof‐of‐Concept Study Using the Clinical Practice Research Datalink

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|94|6|695-701

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.94, Iss.6, 2013-12, pp. : 695-701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy: 2014 Update

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 4, 2014-10 ,pp. : 423-428

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 1, 2012-07 ,pp. : 112-117

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of mitochondria in statin‐induced myopathy

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 7, 2015-07 ,pp. : 745-754

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 5, 2015-05 ,pp. : 955-963

John Wiley & Sons Inc

Access to resources Recommend Favorite

Statin‐induced Myopathy and Ubiquinone Levels in Serum – Results from a Prospective, Observational Study

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 2, 2015-08 ,pp. : 133-136

John Wiley & Sons Inc

Access to resources Recommend Favorite